Sponsor Pipeline

Chengdu Kanghong Pharmaceutical Group Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
0
Recruiting
3
Phase 3
2
Disease Areas
6
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-29 NCT07096791
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum…
Completed without a posted recruiting period
2026-07-29 NCT07096791
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum…
date change Primary completion moved earlier: 2027-01 -> 2026-04-24
2026-07-29 NCT07096791
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum…
date change Completion moved earlier: 2027-04 -> 2026-04-24
2026-07-29 NCT07101120
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents…
Completed without a posted recruiting period
2026-07-29 NCT07101120
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents…
date change Primary completion pushed: 2025-12 -> 2026-02-09
2026-07-29 NCT07101120
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents…
date change Completion moved earlier: 2026-04 -> 2026-02-09
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-03 NCT07741240 A Study of KH607 as Monotherpy in Adults Participants With Major Depressive Disorder Phase 3 Not Yet Recruiting
2026-08-03 NCT07741331 Compare the Efficacy and Safety of KH607 Tablets Versus Vortioxetine Hydrobromide Tablets… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
3
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06589817 A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients… Acute Schizophrenia Not Yet Recruiting
NCT07741240 A Study of KH607 as Monotherpy in Adults Participants With Major Depressive Disorder Major Depressive Disorder (MDD) Not Yet Recruiting
NCT07741331 Compare the Efficacy and Safety of KH607 Tablets Versus Vortioxetine Hydrobromide Tablets… Major Depressive Disorder (MDD) Not Yet Recruiting
Phase 1
NCT07044960 A Phase 1 Study of KHN702 Tablets in Healthy Subjects Healthy Not Yet Recruiting
NCT07277933 Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects Postoperative Pain Not Yet Recruiting
NCT07557537 A Phase 1 Study of KHN707 Tablets in Healthy Participants Healthy Adult Participants Not Yet Recruiting
NCT07634874 A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety… Food Effect of KH607 in Chinese Health Participants Not Yet Recruiting
Disease Areas
Get alerts when Chengdu Kanghong Pharmaceutical Group Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free